Edition:
United States

Opexa Therapeutics Inc (OPXA.OQ)

OPXA.OQ on NASDAQ Stock Exchange Capital Market

0.60USD
11:38am EDT
Change (% chg)

$0.00 (+0.25%)
Prev Close
$0.60
Open
$0.59
Day's High
$0.61
Day's Low
$0.59
Volume
1,970
Avg. Vol
64,323
52-wk High
$4.92
52-wk Low
$0.50

Latest Key Developments (Source: Significant Developments)

Opexa Therapeutics reports Q2 loss per share $0.30
Thursday, 11 Aug 2016 04:01pm EDT 

Opexa Therapeutics Inc : Opexa Therapeutics reports second quarter 2016 financial results and provides corporate update . Q2 loss per share $0.30 .Q2 earnings per share view $-0.23 -- Thomson Reuters I/B/E/S.  Full Article

Opexa Therapeutics Q1 loss per share $0.31
Thursday, 12 May 2016 04:01pm EDT 

Opexa Therapeutics Inc : Opexa therapeutics reports first quarter 2016 financial results and provides corporate update .Q1 loss per share $0.31.  Full Article

Opexa Therapeutics, Inc says granting of new t-cell patents covering tcelna
Tuesday, 6 Oct 2015 07:00am EDT 

Opexa Therapeutics, Inc:Says granting of new t-cell patents covering tcelna.  Full Article

Opexa Therapeutics Inc secures private funding
Tuesday, 1 Sep 2015 06:00am EDT 

Opexa Therapeutics Inc:Secures private funding for its nmo orphan development program, including planned phase i/ii clinical study.Says entered into a stock purchase agreement with a private investor to fund the company's nmo program.Stock purchase agreement with a private investor for up to $5 million, upon achievement of certain pre-specified milestones.  Full Article

More From Around the Web

BRIEF-Opexa Therapeutics quarterly loss per share $0.12

* Opexa Therapeutics Inc - cash and cash equivalents were $2.8 million as of March 31, 2017, compared to $3.4 million as of December 31, 2016